Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.
Clin Cancer Res. 2007 Jul 15;13(14):4191-200. doi: 10.1158/1078-0432.CCR-07-0110.
Clin Cancer Res. 2007.
PMID: 17634548